These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 937118)

  • 1. The correction, in vitro, of lysosomal enzyme deficiencies by means of immunoglobulin-coated liposomes.
    Weissman G; Cohen C; Hoffstein S
    Adv Exp Med Biol; 1976; 68():509-521. PubMed ID: 937118
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes.
    Cohen CM; Weissmann G; Hoffstein S; Awasthi YC; Srivastava SK
    Biochemistry; 1976 Jan; 15(2):452-60. PubMed ID: 1247530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental enzyme replacement in genetic and other disorders.
    Weissmann G
    Hosp Pract; 1976 Sep; 11(9):49-58. PubMed ID: 1071086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells.
    Weissmann G; Bloomgarden D; Kaplan R; Cohen C; Hoffstein S; Collins T; Gotlieb A; Nagle D
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):88-92. PubMed ID: 1054517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tay-Sachs disease: prospects for therapeutic intervention.
    Desnick RJ; Goldberg JD
    Prog Clin Biol Res; 1977; 18():129-41. PubMed ID: 601073
    [No Abstract]   [Full Text] [Related]  

  • 6. Gm2-gangliosidosis: studies in cultured fibroblasts.
    Kolodny EH; Milunsky A; Sheng GS
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):130-5. PubMed ID: 4611525
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of (dihydro)cytochalasin B, colchicine, monensin and trifluoperazine on uptake and processing of liposomes by Kupffer cells in culture.
    Dijkstra J; van Galen M; Scherphof G
    Biochim Biophys Acta; 1985 Apr; 845(1):34-42. PubMed ID: 3978127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages.
    Derksen JT; Morselt HW; Scherphof GL
    Biochim Biophys Acta; 1988 Sep; 971(2):127-36. PubMed ID: 2844282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pinocytosis by cytochalasin B. Decrease in intracellular lysosomal-enzyme activities and increased storage of glycosaminoglycans.
    von Figura K; Kresse H
    Eur J Biochem; 1974 Oct; 48(2):357-63. PubMed ID: 4280968
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorders of ganglioside metabolism.
    Brady RO; Kolodny EH
    Prog Med Genet; 1972; 8():225-41. PubMed ID: 4336471
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of enzymatic induction.
    Applegarth DA; Dunn HG
    N Engl J Med; 1972 Jul; 287(3):148-9. PubMed ID: 5032277
    [No Abstract]   [Full Text] [Related]  

  • 12. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages.
    Derksen JT; Morselt HW; Scherphof GL
    Biochim Biophys Acta; 1987 Oct; 931(1):33-40. PubMed ID: 3651512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
    Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
    Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier screening techniques for Tay-Sachs and other lysosomal storage diseases.
    Kolodny EH
    Prog Clin Biol Res; 1977; 18():213-9. PubMed ID: 601077
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction of missing enzymes into the cytoplasm of cultured mammalian cells by means of fusion-prone liposomes.
    Weissmann G; Cohen C; Hoffstein S
    Trans Assoc Am Physicians; 1976; 89():171-83. PubMed ID: 1020120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical studies in mucolipidoses II and III.
    Shapiro LJ; Hickman S; Hall CW; Neufeld EF
    Birth Defects Orig Artic Ser; 1975; 11(6):301-5. PubMed ID: 127631
    [No Abstract]   [Full Text] [Related]  

  • 17. A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts.
    Hickman S; Shapiro LJ; Neufeld EF
    Biochem Biophys Res Commun; 1974 Mar; 57(1):55-61. PubMed ID: 4364008
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of zymosan-induced release of lysosomal enzymes from human polymorphonuclear leukocytes by cytochalasin B.
    Skosey JL; Damgaard E; Chow D; Sorensen LB
    J Cell Biol; 1974 Sep; 62(3):625-34. PubMed ID: 4853241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kupffer cells and dyslipoidoses].
    Lageron A
    Med Chir Dig; 1977; 6(7):453-7. PubMed ID: 416305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.